LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10127-1 | Dovitinib | TKI_258; TKI258 | LSM-1127 | 49830557 | |
10069-1 | Enzastaurin | LY317615 | LSM-1069 | 176167 | |
10097-1 | Erlotinib | OSI-774 | LSM-1097 | 176870 | |
10141-1 | Fedratinib | SAR 302503; SAR-302503; SAR302503; TG 101348; Tg-101348; TG101348 | LSM-1142 | 16722836 | |
10157-1 | Foretinib | XL880; GSK1363089 | LSM-1158 | 42642645 | |
10234-1 | GDC-0980 | RG7422 | LSM-4257 | 66694608 | |
10098-1 | Gefitinib | ZD1839; Iressa | LSM-1098 | 123631 | |
10108-1 | Geldanamycin | LSM-42789 | 644250 | ||
10172-1 | GSK1059615 | LSM-1173 | 71317162 | ||
10134-1 | GSK1904529A | LSM-1134 | 25124816 | ||
10128-1 | GSK 690693 | LSM-1128 | 16048642 | ||
10014-1 | GW843682X | GW843682 | LSM-1014 | 9826308 | |
10015-1 | HG-5-113-01 | LSM-5982 | 25226483 | ||
10016-1 | HG-5-88-01 | LSM-5245 | 25226117 | ||
10017-1 | HG-6-64-01 | KIN001-206 | LSM-43248 | ||
10023-1 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 | 5291 | |
10100-1 | JNK-9L | KIN001-204 | LSM-36386 | 25222038 | |
10019-1 | JW-7-24-1 | LSM-5674 | 69923936 | ||
10031-1 | KIN001-043 | LSM-42780 | 24906282 | ||
10051-1 | Lapatinib | GW-572016; Tykerb | LSM-1051 | 208908 | |
10115-1 | LDN-193189 | DM 3189 | LSM-1115 | 25195294 | |
10182-1 | Linifanib | ABT-869; AL-39324 | LSM-1183 | 11485656 | |
10135-1 | Linsitinib | OSI 906 | LSM-1135 | 11640390 | |
10161-1 | Luminespib | NVP-AUY922 | LSM-1162 | 53401173 | |
10479-1 | Mitoxantrone | CL 232325; CL-232325; DHAQ; Novantron; Novantrone | LSM-2481 | 4212 |